Latest Content

In the final episode of the short series, Akhila Kosaraju, MD, talks about changing the development paradigm and moving away from reengineering molecules of existing antibiotic classes and towards creating new ones.

Madeline McCrary, MD, explains her institution’s program as a novel way to get new mothers diagnosed and given their full-course of treatment when they are still in the hospital.

Study ascertains vaccination status of children hospitalized for Bordetella pertussis infections and assesses diagnostic value of testing modalities.

In the second episode of this short series, Akhila Kosaraju, MD, talks about how Phare Bio and Basilea Pharmaceuticals are partnering to develop antimicrobials taking them from AI molecules to clinical trials.

A nurse’s decades-long advocacy highlights how personal loss and gaps in public education have shaped ongoing challenges in hepatitis B vaccination and liver disease awareness.

A new study shows that strain-level surveillance of Staphylococcus aureus in NICUs can identify hidden transmission pathways and enable targeted interventions to reduce serious infections in vulnerable newborns.

Akhila Kosaraju, MD, provides insights around how AI is moving towards an accelerated pace of antimicrobial development in hopes of getting molecules into clinical trials and approved much faster than the current paradigm.

Study examines how clinicians consider rapid pneumonia panel test results in prescribing antibiotics in the ICU.

The latest CDC numbers show a 2.57% increase of measles cases from week-to-week. This is a significant decrease in the percentage of cases from last week where there was a 6.1% increase.

A large cluster-randomized trial in Singapore found that releasing sterile male Wolbachia-infected mosquitoes greatly reduced dengue infections by suppressing local mosquito populations.

The inaugural MAD-ID and SIDP 2026 meeting aims to provide new infectious diseases education offerings, dynamic speakers, and strong networking opportunities for younger clinicians. SIDP President Erin McCreary, PharmD, BCIDP, FIDSA, offers some insights around the upcoming event.

Investigators identified behavioral determinants of being tested for pathogen exposure, in interviewing a focus group presented with a hypothetical avian influenza outbreak.

Early adoption of genomic surveillance and rigorous infection prevention protocols has enabled one health system to prevent in-hospital outbreaks of Candida auris despite rising cases nationwide. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP) provides insights on how his institution is handling testing for this problematic fungal infection.